Alkermes Acquires Avadel, Expands Sleep Health Business – Merger Arbitrage Mondays
Avadel Pharmaceuticals plc (AVDL): $18.56
Market Cap: $1.79B
Deal Size: $2.1B
This week, we are writing about not one, but two new deals with CVRs that we find interesting, including one that we added to our portfolio earlier this year when it was trading at less than half of its acquisition price.
Alkermes plc (ALKS) entered a merger agreement on October 2…
Keep reading with a 7-day free trial
Subscribe to The Special Situation Report to keep reading this post and get 7 days of free access to the full post archives.

